清肝化瘀颗粒对二乙基亚硝胺所致原发性肝癌大鼠的治疗作用  

Therapeutic effect of Qinggan Huayu granule on diethylnitrosamine-induced primary liver cancer rats

作　　者：朱晓燃 杨振寰[1] 索菲娅 姚树坤[2] ZHU Xiaoran;YANG Zhenhuan;SUO Feiya;YAO Shukun(Beijing University of Traditional Chinese Medicine,Beijing,100029,China;Department of Gastroenterology,China-Japanese Friendship Hospital)

机构地区：[1]北京中医药大学,北京100029 [2]中日友好医院消化科

出　　处：《中国中西医结合消化杂志》2021年第3期161-165,共5页Chinese Journal of Integrated Traditional and Western Medicine on Digestion

基　　金：北京市科委G20工程创新研究十病十药研发项目(No:Z171100001717008)。

摘　　要：目的:研究清肝化瘀颗粒对二乙基亚硝胺(DEN)所致原发性肝癌大鼠的治疗作用。方法:将162只雄性SD大鼠随机平均分为模型组、肝复乐组、化疗药组及清肝化瘀颗粒低、中、高剂量组。应用DEN腹腔注射法制备原发性肝癌大鼠模型,分别给予生理盐水10 mL/(kg·d)灌胃,肝复乐组0.94 g/(kg·d)灌胃,氟尿嘧啶注射液50 mg/(kg·w)腹腔注射,清肝化瘀颗粒0.47、0.93、1.86 g/(kg·d)灌胃,连续给药8周。末次给药后各组随机选取6只大鼠解剖,观察肝脏成癌情况,检测血清肝功能。结果:清肝化瘀颗粒组大鼠的肝脏大体与病理组织学癌变程度均较模型组减轻明显;清肝化瘀颗粒组肝指数较模型组显著降低,中、高剂量组肝脏表面癌结节数显著低于模型组(P<0.05);清肝化瘀颗粒可显著降低血清TBIL、GGT、AFU水平(P<0.05或P<0.01),且中、高剂量组以及化疗药组分别具有显著降低血清ALP、AST水平的作用(P<0.05)。结论:清肝化瘀颗粒能够有效缓解DEN诱导原发性肝癌大鼠的肝损伤,改善其肝功能。Objective:To observe the therapeutic effect of Qinggan Huayu granule on primary liver cancer(PLC)rats induced by diethylnitrosamine(DEN).Methods:One hundred and sixty-two SD male rats were randomly divided into model group,Ganfule group,and chemotherapeutic group,low-group,medium-group,and high-dose of Qinggan Huayu granule groups.Rat models of primary liver cancer were prepared by DEN intraperitoneal injection method,and saline at does of 10 mL/(kg·d),Qinggan Huayu granule at does of 0.47 g/(kg·d),0.93 g/(kg·d),1.86 g/(kg·d),Ganfule at does of 0.94 g/(kg·d)for gavage and fluorouracil 50 mg/(kg·w)intraperitoneal injection were given for 8 weeks.After the last administration,six rats was randomly selected from each group for dissection toobserve the incidence of liver cancer and detect serum liver function.Results:The degree of gross and histopathological of liver cancer rats of Qinggan Huayu granule group were significantly reduced compared with that of model group.The liver index of Qinggan Huayu granule group was significantly lower than the model group,and the number of carcinoma nodules on the liver surface of the medium and high dose groups was significantly lower than that of the model group(P<0.05).The serum TBIL,GGT and AFU levels were significantly reduced by Qinggan Huayu granule(P<0.05 or P<0.01),in addition,the serum ALP and AST levels could be significantly reduced by medium-dose,high-dose of Qinggan Huayu granule groups and chemotherapeutic group respectively(P<0.05).Conclusion:Qinggan Huayu granule can effectively relieve the liver injury of DEN-induced primary liver cancer in rats and improve liver function.

关 键 词：原发性肝癌 二乙基亚硝胺 清肝化瘀颗粒 肝功能 

分 类 号：R735.7[医药卫生—肿瘤]